Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 35,275 |
|
|||||
| News | - | ||||||
| Day High | 13.72 | Low High |
|||||
| Day Low | 13.375 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Alvontech | ALVO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.20 | -1.47% | 13.40 | 14:23:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 13.72 | 13.375 | 13.72 | 13.60 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 556 | 35,275 | $ 13.51 | $ 476,552 | - | 6.70 - 18.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:31:26 | 10 | $ 13.41 | USD |
Alvontech Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.53B | 263.51M | - | 93.38M | -551.73M | -2.09 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alvontech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.49 | 14.4922 | 13.375 | 14.00 | 91,262 | -1.09 | -7.52% |
| 1 Month | 11.79 | 14.76 | 11.19 | 13.36 | 243,361 | 1.61 | 13.66% |
| 3 Months | 15.87 | 18.00 | 11.0101 | 14.65 | 252,636 | -2.47 | -15.56% |
| 6 Months | 8.70 | 18.00 | 8.70 | 14.27 | 224,492 | 4.70 | 54.02% |
| 1 Year | 9.28 | 18.00 | 6.70 | 12.96 | 146,925 | 4.12 | 44.40% |
| 3 Years | 9.50 | 18.00 | 5.20 | 12.04 | 115,845 | 3.90 | 41.05% |
| 5 Years | 9.50 | 18.00 | 5.20 | 12.04 | 115,845 | 3.90 | 41.05% |
Alvontech Description
| Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases. |
